GlassScriptPhysician profile
Grace Breuer
NPI 1699331199
$308.60
in general payments reported to CMS, 2019-2025
10 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $51.06 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $49.25 | 2025 | Veozah |
| Indivior INC. | $48.57 | 2024-2025 | Sublocade |
| Corium, LLC | $47.01 | 2025 | Azstarys |
| Lilly USA, LLC | $33.66 | 2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $31.34 | 2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Janssen Pharmaceuticals, INC | $26.10 | 2024 | Spravato |
| Novo Nordisk INC | $22.50 | 2025 | Rybelsus, Ozempic |
| Neurocrine Biosciences, INC. | $21.29 | 2025 | |
| Dexcom, INC. | $15.41 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $13.47 | 2025 | Nexium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Breuer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.